🟢 Relay Therapeutics Inc is trading 4.2% up today on zovegalisib momentum and rebound from equity raise

Relay Therapeutics Inc is trading 4.2% up today at $14.84 as shares continue to rebound from recent volatility following a $275 million equity offering priced at $12 per share.

• The stock is benefiting from sustained momentum surrounding its zovegalisib program, which recently received FDA Breakthrough Therapy designation following positive clinical data.
• Analyst sentiment remains supportive with favorable price targets, contributing to a sharp climb in share value over the past month.
• The current gains are being extended alongside a broadly positive trend in the equity markets.